Skin cells have been used to characterize specific cellular problems in people with Parkinson’s, in a new approach that may help match them to particular drugs that may work best for them.
PINK1 may also protect cells and the brain from autoimmune attack
Insights into pathways in mitochondria and oxidative stress
Wide range of evidence supporting potential interactions
Funding now sought for human MSDC-0160 trials.